Scientists at a Melbourne research institute in Australia have found that a medicine used to treat blood cancer can kill HIV cells. Know in...

There is no reported stock out for any antiretroviral (ARV) drugs at the state level and fresh supply orders for procurement of the next lo...

South African Health Products Regulatory Authority (SAHPRA) has approved the sweet-tasting, heat-stable and '4-in-1' fixed-dose combination...

The drug maker's product is the generic version of Gilead Sciences, Inc's Truvada tablets and indicated in combination with other antiretro...

Experts meets pharma execs seeking enough stock of Lopinavir and Ritonavir to be kept ready for India.

The Indian Council of Medical Research (ICMR) has approval from the Drug Controller General of India (DCGI) to allow a combination of lopin...

A 20-year-old who began therapy in 2008 can now live up to 78 years, says a new study.

JP Nadda said India will need to "front load" its investments substantially to almost double the number of people on ARV treatment in less ...

Globally, life expectancy increased by 5 years between 2000 and 2015, the fastest increase since the 1960s, according to a latest WHO repor...

"As per India HIV estimation 2015 report, an estimated 21.17 lakh people are living with HIV", Health Minister J P Nadda said.

Those with HIV, often struggle with declining health because their immune systems can not effectively respond to common pathogens.

India has been able to achieve a more than 20% decline in new HIV infections between 2000 and 2014, according to a UN report.

In the WHO South-East Asia region, as of 2013, there were around 3.4 million people living with HIV and 1.1 million of them are currently o...

Scientists used radioimmunotherapy to destroy remaining human immunodeficiency virus -infected cells in the blood samples of patients treat...

An Indian manufacturer of drugs to treat HIV/AIDS is suing the South African government after failing to clinch a $400-million tender, Sout...

The groups said India's ability to manufacture low cost generic versions of newer medicines would be threatened if Norvatis won the suit.

Aurobindo Pharma Ltd on Wednesday said it has received tentative approval by USFDA for its anti-HIV drug, Didanosine chewable tablets of 10...